Please assess the completion status of the following clinical trial:

Trial Title: Feasibility and Safety of Neoadjuvant Chemotherapy (FLOT ) for Gastric Cancer Patients in China

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Sex: all~* Histology confirmed adenocarcinoma of the stomach or esophagogastric junction.~* Clinical stage: Clinical Tumor-Node-Metastasis (cTNM): stage III，IVa~* Performance status: Eastern Cooperative Oncology Group ECOG 0- 2~* Adequate renal, hepatic, hematologic, and pulmonary function.~* Written informed consent~Exclusion Criteria:~* Uncontrolled cardiac disease, or other clinically significant uncontrolled comorbidities~* Distant metastases~* Prior chemo or radiotherapy~* Inclusion in another clinical trial~* Known contraindications or hypersensitivity for planned chemotherapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Neoadjuvant chemotherapy (Type: None): FLOT Chemotherapy regimen~A cycle consist of Day 1: 5-fluorouracil (5-FU) 2600mg/M2 intravenous Via peripherally inserted central catheter (PICC) for 24 hour Day 1: Leucovorin 200mg/M2 intravenous Day 1: Oxaliplatin 85mg/ M2 intravenous Day 1: Docetaxel 50mg/M2 intravenous Repeated every 15th day

Based on this trial design, predict the completion outcome and termination type (if applicable).